Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Chi-Med
Chi-Med
Chi-Med stops pivotal pancreatic cancer trial upon early success
Fierce Biotech
Tue, 01/21/20 - 11:56 am
Chi-Med
clinical trials
surufatinib
pancreatic cancer
ESMO: Eyeing Novartis and Pfizer, Chi-Med touts neuroendocrine cancer win
Fierce Pharma
Mon, 09/30/19 - 10:38 am
Chi-Med
surufatinib
Pfizer
Sutent
Novartis
Afinitor
Lutathera
neuroendocrine tumors. ESMO
Chi-Med Halts Phase III Study Early After Meeting Primary Endpoint
BioSpace
Fri, 06/14/19 - 06:20 pm
Chi-Med
neuroendocrine tumors
clinical trials
surufatinib
Chi-Med, AstraZeneca's savolitinib helps some Tagrisso-resistant EGFR lung cancer patients
Fierce Pharma
Sun, 03/31/19 - 03:44 pm
Chi-Med
savolitinib
AstraZeneca
Tagrisso
EGFR lung cancer
Boost for "made in China" medicine as Chi-Med wins key approval
Yahoo/Reuters
Wed, 09/5/18 - 09:08 am
China
Chi-Med
Eli Lilly
fruquintinib
colorectal cancer
Unstoppable growth of Chinese biotechs attracts over $10bn funding
GoinPharma
Mon, 11/27/17 - 09:07 am
China
biotech
Zensun
BeiGene
Chi-Med
Zai Lab
WuXi
Billionaire-backed Chi-Med declares PhIII success for pioneering cancer drug in China, seeking quick OK
Endpoints
Sat, 03/4/17 - 12:32 pm
Chi-Med
fruquintinib
oncology
cancer
China
Chi-Med Arthritis Drug Spurs Interest From Possible Partners
Bloomberg
Fri, 06/19/15 - 10:06 am
Chi-Med
HMPL-523
rheumatoid arthritis
Imbruvica
AbbVie
Chi-Med's fruquintinib meets colorectal cancer PhII primary endpoint
Fierce Biotech
Tue, 03/31/15 - 04:07 pm
Chi-Med
fruquintinib
colorectal cancer
China Biotech Week In Review: Simcere Pharma Going Private
Seeking Alpha
Sun, 12/22/13 - 12:35 pm
China
Chengdu Kanghong Pharmaceutical Group
MicuRx Pharmaceuticals
Alvogen
Lotus
Chi-Med
Sinopharm
Simcere
GSK
Shanghai Pharmaceutical
China Biotech In Review: Hutchison MediPharma Partners Cancer Drug With Lilly
Seeking Alpha
Sun, 10/13/13 - 12:53 pm
Hutchison MediPharma
Chi-Med
Aslan Pharma
Eddingpharm
Shenzhen Chipscreen Biosciences
Sihuan Pharma
China National Biotech Group
China Biotech In Review: Sagent Buys Out China JV Partner For $25 Million
Seeking Alpha
Sun, 05/12/13 - 11:09 am
ScinoPharm
Sagent Pharmaceuticals
Huahai Pharma
Oncobiologics
Chi-Med
Beta Pharma
Amgen
Beijing Leadman Biochemistry
Nestle Forms Botanical-Medicine Venture With Li’s Chi-Med
Bloomberg
Wed, 11/28/12 - 10:53 am
Nestle
Chi-Med
traditional Chinese medicine
China Biotech Week In Review: Mindray Medical Continues On Acquisition Path
Seeking Alpha
Sun, 06/10/12 - 11:17 am
Mindray
ShangPharma
Eli Lilly
WuXi PharmaTech
Hutchison MediPharma
Chi-Med
China Biotech Week in Review: China Life Science to Grow 22% Yearly Through 2013
Seeking Alpha
Mon, 03/8/10 - 09:04 am
China
WuXi PharmaTech
Chi-Med
Biostar Pharmaceuticals
Sanofi